{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T23:21:04Z","timestamp":1794093664671,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"vor","delay-in-days":47,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.parkreldis.2020.09.024","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T22:29:58Z","timestamp":1608330598000},"page":"S7-S12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"special_numbering":"S1","title":["Unmet needs in Parkinson disease: Motor and non-motor"],"prefix":"10.1016","volume":"80","author":[{"given":"Peter A.","family":"LeWitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Ray","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.parkreldis.2020.09.024_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3233\/JPD-140446","article-title":"A survey of Parkinson's disease patients: most bothersome symptoms and coping preferences","volume":"4","author":"Uebelacker","year":"2014","journal-title":"J. Parkinsons Dis."},{"issue":"5","key":"10.1016\/j.parkreldis.2020.09.024_bib2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/practneurol-2013-000741","article-title":"Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected","volume":"14","author":"Todorova","year":"2014","journal-title":"Practical Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2020.09.024_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-0037-1601869","article-title":"The phenomenology of Parkinson's disease","volume":"37","author":"Hess","year":"2017","journal-title":"Semin. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2020.09.024_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/JPD-171233","article-title":"What is functional mobility applied to Parkinson's disease?","volume":"8","author":"Bou\u00e7a-Machado","year":"2018","journal-title":"J. Parkinsons Dis."},{"issue":"14 Suppl 1","key":"10.1016\/j.parkreldis.2020.09.024_bib5","first-page":"S3","article-title":"Levodopa therapy for Parkinson disease: a look backward and forward","volume":"86","author":"LeWitt","year":"2016","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1016\/j.parkreldis.2020.09.024_bib6","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1007\/s00415-010-5741-y","article-title":"A brief history of levodopa","volume":"257","author":"Hornykiewicz","year":"2010","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.parkreldis.2020.09.024_bib7","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/jama.1969.03160070046011","article-title":"Amantadine in the treatment of Parkinson's disease","volume":"208","author":"Schwab","year":"1969","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.parkreldis.2020.09.024_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.parkreldis.2020.09.024_bib9","article-title":"Safety and efficacy of magnetic resonance imaging-guided focused ultrasound neurosurgery for Parkinson's disease: a systematic review","author":"Xu","year":"2019","journal-title":"Neurosurg. Rev."},{"issue":"2","key":"10.1016\/j.parkreldis.2020.09.024_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mdc3.12266","article-title":"Clozapine in parkinsonian rest tremor: a review of outcomes, adverse reactions, and possible mechanisms of action","volume":"3","author":"Yaw","year":"2016","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"10.1016\/j.parkreldis.2020.09.024_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy","volume":"14","author":"Parkinson","year":"1817","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"11","key":"10.1016\/j.parkreldis.2020.09.024_bib12","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/mds.27460","article-title":"Speech treatment in Parkinson's disease: randomized controlled trial (RCT)","volume":"33","author":"Ramig","year":"2018","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2020.09.024_bib13","first-page":"355","article-title":"The association of balance, fear of falling, and daily activities with drug phases and severity of disease in patients with Parkinson","volume":"10","author":"Mehdizadeh","year":"2019","journal-title":"Basic Clin. Neurosci."},{"issue":"Suppl 7","key":"10.1016\/j.parkreldis.2020.09.024_bib14","first-page":"VII14","article-title":"Camptocormia in Parkinson's disease","volume":"253","author":"Melamed","year":"2006","journal-title":"J. Neurol."},{"issue":"Suppl 7","key":"10.1016\/j.parkreldis.2020.09.024_bib15","first-page":"Vii7","article-title":"Dystonia in Parkinson's disease","volume":"253","author":"Tolosa","year":"2006","journal-title":"J. Neurol."},{"issue":"10","key":"10.1016\/j.parkreldis.2020.09.024_bib16","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S1474-4422(16)30173-9","article-title":"Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment","volume":"15","author":"Barone","year":"2016","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2020.09.024_bib17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2020.09.024_bib18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.parkreldis.2011.03.014","article-title":"The long-duration response to levodopa: phenomenology, potential mechanisms and clinical implications","volume":"17","author":"Anderson","year":"2011","journal-title":"Park. Relat. Disord."},{"issue":"9","key":"10.1016\/j.parkreldis.2020.09.024_bib19","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S1474-4422(18)30284-9","article-title":"At last, a randomised controlled trial of apomorphine infusion","volume":"17","author":"LeWitt","year":"2018","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.parkreldis.2020.09.024_bib20","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S1474-4422(15)00041-1","article-title":"Freezing of gait: a practical approach to management","volume":"14","author":"Nonnekes","year":"2015","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.parkreldis.2020.09.024_bib21","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/brain\/awz141","article-title":"Freezing of gait in Parkinson's disease reflects a sudden derangement of locomotor network dynamics","volume":"142","author":"Pozzi","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2020.09.024_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41531-018-0067-z","article-title":"Levodopa Phobia': a review of a not uncommon and consequential phenomenon","volume":"4","author":"Titova","year":"2018","journal-title":"NPJ Parkinson's disease."},{"issue":"12","key":"10.1016\/j.parkreldis.2020.09.024_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226916","article-title":"Experiences of health services and unmet care needs of people with late-stage Parkinson's in England: a qualitative study","volume":"14","author":"Read","year":"2019","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.parkreldis.2020.09.024_bib24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/147323000903700315","article-title":"Unmet needs of patients with Parkinson's disease: interview survey of patients and caregivers","volume":"37","author":"Hatano","year":"2009","journal-title":"J. Int. Med. Res."},{"issue":"9","key":"10.1016\/j.parkreldis.2020.09.024_bib25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5694\/mja17.00993","article-title":"Non-motor Parkinson disease: new concepts and personalised management","volume":"208","author":"Titova","year":"2018","journal-title":"Med. J. Aust."},{"issue":"7","key":"10.1016\/j.parkreldis.2020.09.024_bib26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.parkreldis.2020.09.024_bib27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.parkreldis.2019.04.014","article-title":"Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson's","volume":"64","author":"Hurt","year":"2019","journal-title":"Park. Relat. Disord."},{"issue":"7","key":"10.1016\/j.parkreldis.2020.09.024_bib28","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/mds.20844","article-title":"International multicenter pilot study of the first comprehensive self\u2010completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study","volume":"21","author":"Chaudhuri","year":"2006","journal-title":"Mov. Disord."},{"issue":"13","key":"10.1016\/j.parkreldis.2020.09.024_bib29","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/mds.21596","article-title":"The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study","volume":"22","author":"Chaudhuri","year":"2007","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2020.09.024_bib30","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mds.22868","article-title":"The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire","volume":"25","author":"Chaudhuri","year":"2010","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2020.09.024_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mds.27862","article-title":"The movement disorder society nonmotor rating scale: initial validation study","volume":"35","author":"Chaudhuri","year":"2020","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.parkreldis.2020.09.024_bib32","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson's disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2020.09.024_bib33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/mds.27670","article-title":"Prodromal Parkinson's disease: the decade past, the decade to come","volume":"34","author":"Postuma","year":"2019","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2020.09.024_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/mds.23462","article-title":"The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease","volume":"26","author":"Martinez-Martin","year":"2011","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2020.09.024_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/14737175.2018.1400383","article-title":"Comprehensive grading of Parkinson's disease using motor and non-motor assessments: addressing a key unmet need","volume":"18","author":"Martinez-Martin","year":"2018","journal-title":"Expert Rev. Neurother."},{"issue":"12","key":"10.1016\/j.parkreldis.2020.09.024_bib36","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1080\/03007995.2018.1502165","article-title":"Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach","volume":"34","author":"Antonini","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"issue":"8","key":"10.1016\/j.parkreldis.2020.09.024_bib37","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00702-016-1667-6","article-title":"A syndrome rather than a disease?","volume":"124","author":"Titova","year":"2017","journal-title":"J. Neural. Transm."},{"issue":"10","key":"10.1016\/j.parkreldis.2020.09.024_bib38","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00702-015-1405-5","article-title":"Neuropathobiology of non-motor symptoms in Parkinson disease","volume":"122","author":"Jellinger","year":"1996","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.parkreldis.2020.09.024_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.irn.2017.05.018","article-title":"Nonmotor symptoms in experimental models of Parkinson's disease","volume":"133","author":"Titova","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2020.09.024_bib40","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.parkreldis.2015.09.027","article-title":"Non motor subtypes and Parkinson's disease","volume":"22","author":"Sauerbier","year":"2016","journal-title":"Park. Relat. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2020.09.024_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070244","article-title":"The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients","volume":"8","author":"Erro","year":"2013","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.parkreldis.2020.09.024_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mds.26077","article-title":"The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study)","volume":"30","author":"Pont-Sunyer","year":"2015","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2020.09.024_bib43","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/mds.26510","article-title":"Nonmotor features of Parkinson's disease subtypes","volume":"31","author":"Marras","year":"2016","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2020.09.024_bib44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2020.09.024_bib45","first-page":"10","article-title":"Gut microbiota and Parkinson's disease: background and rationale of the SymPD study","author":"Leta","year":"2019","journal-title":"Neurodigest"},{"key":"10.1016\/j.parkreldis.2020.09.024_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(13)70293-X","article-title":"Continuous intrajejunal infusion of levodopa-carbidopa intestinal get for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study","volume":"13","author":"Olanow","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2020.09.024_bib47","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1474-4422(18)30239-4","article-title":"Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial","volume":"17","author":"Katzenschlager","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2020.09.024_bib48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ensci.2018.09.001","article-title":"Reversible istradefylline-induced pleurothotonus in a patient with Parkinson's disease: a case report and literature review","volume":"13","author":"Yasuda","year":"2017","journal-title":"eNeurolSci"},{"key":"10.1016\/j.parkreldis.2020.09.024_bib49","doi-asserted-by":"crossref","DOI":"10.5334\/tohm.429","article-title":"Istradefylline for restless legs syndrome associated with Parkinson's disease","author":"Nuermaimaiti","year":"2018","journal-title":"Tremor. Other. Hyperkin. Disord."},{"key":"10.1016\/j.parkreldis.2020.09.024_bib50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/WNF.0000000000000281","article-title":"Long-term outcome of adenosine A2A receptor antagonist on lower urinary tract symptoms in male Parkinson disease patients","volume":"41","author":"Kitta","year":"2017","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.parkreldis.2020.09.024_bib51","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1080\/14656566.2019.1614167","article-title":"Effect of istradefylline for gait disorders with freezing of gait in Parkinson's disease: a single-arm, open-label prospective study","volume":"20","author":"Iijima","year":"2019","journal-title":"Expet Opin. Pharmacother."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020307380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020307380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:21:31Z","timestamp":1761178891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802020307380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":51,"alternative-id":["S1353802020307380"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.09.024","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmet needs in Parkinson disease: Motor and non-motor","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}